Legal Opinion
King Drug Co. of Florence, Inc. v. Cephalon, Inc.
District Court, E.D. Pennsylvania
Decided July 27, 2015No. Civil Action No. 2:06-cv-1797PublishedCited by 6 opinions
1Opinion of the Court
MEMORANDUM OPINION
GOLDBERG, District Judge.
Presently before me is the Direct Purchaser Class Plaintiffs’ motion for class certification filed in this consolidated antitrust lawsuit known as the In re Modafinil Litigation.1 The prospective class of Direct Purchasers include drug wholesalers that purchased the brand-name drug, Provigil, directly from Defendant, Cephalon, Inc., at any time between June 24, 2006 and August 31, 2012.
Plaintiffs have brought this antitrust lawsuit against the manufacturer of Provigil, Cephalon, Inc., as well as four generic pharmaceutical companies: Teva…
2Cases cited41 opinions
- Amchem Products, Inc. v. WindsorSupreme Court of the United States · 1997
- Wal-Mart Stores, Inc. v. DukesSupreme Court of the United States · 2011
- Califano v. YamasakiSupreme Court of the United States · 1979
- Comcast Corp. v. BehrendSupreme Court of the United States · 2013
- Amgen Inc. v. Connecticut Retirement Plans and Trust FundsSupreme Court of the United States · 2013
36 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- In Re Modafinil Antitrust LitigationCourt of Appeals for the Third Circuit · 2016
- In re Namenda Direct Purchaser Antitrust Litig.District Court, S.D. Illinois · 2018
- In re Processed Egg Products Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2015
- In re Processed Egg Products Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2015
- In Re Modafinil Antitrust LitigationCourt of Appeals for the Third Circuit · 2016
1 more not listed; retrieve them via the Exa API.